# A Phase 1 Study to Assess Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered to Healthy Volunteers

> **NCT01933997** · PHASE1 · COMPLETED · sponsor: **Alcobra Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** Metadoxine (MG01CI )

## Key facts

- **NCT ID:** NCT01933997
- **Lead sponsor:** Alcobra Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01933997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01933997, "A Phase 1 Study to Assess Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered to Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01933997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*